Haematologica (Jul 2020)
Complement C5 inhibition in patients with COVID-19 - a promising target?
- Regis Peffault de Latour,
- Anne Bergeron,
- Etienne Lengline,
- Thibault Dupont,
- Armance Marchal,
- Lionel Galicier,
- Nathalie de Castro,
- Louise Bondeelle,
- Michael Darmon,
- Clairelyne Dupin,
- Guillaume Dumas,
- Pierre Leguen,
- Isabelle Madelaine,
- Sylvie Chevret,
- Jean-Michel Molina,
- Elie Azoulay,
- Veronique Fremeaux-Bacchi,
- CORE GROUP
Affiliations
- Regis Peffault de Latour
- Saint Louis Hospital;
- Anne Bergeron
- Saint-Louis Hospital;
- Etienne Lengline
- Saint-Louis Hospital;
- Thibault Dupont
- Saint-Louis Hospital;
- Armance Marchal
- HEGP Hospital;
- Lionel Galicier
- Saint-Louis Hospital;
- Nathalie de Castro
- Saint-Louis Hospital;
- Louise Bondeelle
- Saint Louis Hospital;
- Michael Darmon
- Saint-Louis University Hospital
- Clairelyne Dupin
- Saint Louis Hospital;
- Guillaume Dumas
- Saint Louis Hospital;
- Pierre Leguen
- Saint Louis Hospital;
- Isabelle Madelaine
- Saint Louis Hospital;
- Sylvie Chevret
- Saint Louis Hospital;
- Jean-Michel Molina
- Saint Louis Hospital;
- Elie Azoulay
- Saint Louis Hospital;
- Veronique Fremeaux-Bacchi
- HEGP Hospital;
- CORE GROUP
- DOI
- https://doi.org/10.3324/haematol.2020.260117
- Journal volume & issue
-
Vol. 105,
no. 12
Abstract
No abstracts available.